Old Web
English
Sign In
Acemap
>
Paper
>
PD3-1-2: Phase I trial of vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with solid tumors
PD3-1-2: Phase I trial of vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with solid tumors
2007
Yutaka Fujiwara
Noboru Yamamoto
Kazuhiko Yamada
Yasuhide Yamada
Fumiaki Koizumi
Tatsu Shimoyama
Kazuto Nishio
Tetsuya Otsuki
Stanley R. Frankel
Tomohide Tamura
Keywords:
Cancer research
Vorinostat
Pathology
Suberoylanilide Hydroxamic Acid
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]